France
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.28 B
|
June 30, 2024 | USD 11.08 | 0.25% |
|
France |
|
2 |
USD 669.90 M
|
Dec. 31, 2023 | USD 28.77 | 0.25% |
|
France |
|
3 |
USD 463.24 M
|
Dec. 31, 2023 | USD 121.52 | 0.77% |
|
France |
|
4 |
USD 461.08 M
|
Dec. 31, 2023 | USD 28.61 | 0.98% |
|
France |
|
5 |
USD 147.77 M
|
Dec. 31, 2023 | USD 7.91 | 1.05% |
|
France |
|
6 |
USD 146.80 M
|
June 30, 2024 | USD 3.56 | -2.04% |
|
France |
|
7 |
USD 97.44 M
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
8 |
USD 84.54 M
|
Dec. 31, 2023 | USD 1.18 | 2.98% |
|
France |
|
9 |
USD 50.63 M
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
10 |
USD 25.95 M
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
11 |
USD 21.64 M
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
12 |
USD 18.47 M
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
13 |
USD 9.30 M
|
Dec. 31, 2023 | USD 4.49 | 2.38% |
|
France |
|
14 |
USD 8.12 M
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
15 |
USD 7.76 M
|
Dec. 31, 2023 | USD 2.44 | 6.09% |
|
France |
|
16 |
USD 5.25 M
|
Dec. 31, 2023 | USD 3.60 | 1.72% |
|
France |
|
17 |
USD 3.74 M
|
Dec. 31, 2023 | USD 7.60 | -5.89% |
|
France |
|
18 |
USD 3.11 M
|
Dec. 31, 2023 | USD 1.58 | 0.91% |
|
France |
The Medical Instruments company in France with the highest Total Non-Current Liabilities is Ramsay Générale de Santé SA (Paris Stock Exchange: GDS.PA) at USD 4.28 B.
The Medical Instruments company in France with the lowest Total Non-Current Liabilities is Ikonisys S.A. (Paris Stock Exchange: ALIKO.PA) at USD 3.11 M.
The top 10 Medical Instruments companies in France by Total Non-Current Liabilities are Ramsay Générale de Santé SA, Lisi S.A., bioMérieux S.A., Guerbet SA, Lumibird SA, Amplitude Surgical SA, Eurobio Scientific SA, Biosynex SA, Nanobiotix S.A. and Median Technologies SA.
The bottom 10 Medical Instruments companies in France by Total Non-Current Liabilities are Ikonisys S.A., i2S SA, MEMSCAP, S.A., EDAP TMS S.A., Predilife S.A., Euromedis Groupe, Affluent Medical SA, Novacyt S.A., Median Technologies SA and Nanobiotix S.A..